News

Event: Research and development of new tuberculosis vaccines


9 May 2010
by Working Group

TBVI
TBVI

The University of Zaragoza (Spain), together with TuBerculosis Vaccine Initiative (TBVI) and the Spanish Fundación Ramón Areces, presents an international symposium: “Research and Development of new Tuberculosis Vaccines”.

This symposium will be held on 3 and 4 June in Zaragoza, Spain. During the symposium, the latest developments in new vaccines for TB will be discussed. The symposium includes the European conference under the Spanish presidency 2010 ‘Research and development of European TB vaccines for the world’. The event will join European scientists and researchers, world leaders in the field of research of new vaccines against TB, to present and translate to the scientific community and the society their efforts and the results of the latest European scientific research in the most advanced TB vaccines.

The two day event starts off Thursday (June 3) with a scientific program in which several renowned scientists present the latest on research on new TB vaccines, clinical trials of TB vaccines and research and development of European TB vaccines for the world. Followed on Friday by the European conference where representatives of Spanish ministries and among others the European Centre for Disease Prevention and Control (ECDC), the European Commission and the Bill & Melinda Gates Foundation will speak.

For more information about the program and (free) registration: http://www.tbvi.eu/news-agenda/events/event/international-symposium-on-new-tb-vaccines-zaragoza.html

Event Contact:

Ms. Erna Balk
Director Communications & Advocacy Relations
+31 320 29 32 65
erna.balk(at)wur.nl

More News
30 Mar 2021
Médecins Sans Frontières (MSF) published a press release on World TB Day 2021 announcing their clinical trial, TB-Practecal , investigating novel treatment for MDR-TB has stopped enrolling earlier than originally planned due to promising results. The trial's independent data safety and monitoring...
3 Feb 2021
Last week, the World Health Organization (WHO) held a consultation to discuss the definition of extensively drug resistant (XDR) tuberculosis. The meeting was held to discuss novel treatment regimens and diagnostics for drug-resistant TB and determine its impact on the definition of XDR-TB. The...
10 Dec 2020
The Stop TB Partnership Working Group on New TB Vaccines (WGNV), Working Group on New TB Drugs (WGND), and New Diagnostics Working Group (NDWG) are developing an online course specifically designed for advocates and affected communities to provide a base of knowledge in TB research and to generate...